Transducin-Like Enhancer of Split-1 Inhibits Malignant Behaviors in vitro and Predicts a Better Prognosis in Pancreatic Ductal Adenocarcinoma. This evidence concerns the gene TLE1 and pancreatic ductal adenocarcinoma.